Genre
Journal ArticleDate
2012-05-01Author
Murrell, Bde Oliveira, T
Seebregts, C
Kosakovsky Pond, SL
Scheffler, K
Subject
Anti-HIV AgentsBiological Evolution
Computer Simulation
Drug Resistance, Viral
Evolution, Molecular
Genetic Variation
HIV-1
Models, Genetic
Selection, Genetic
Permanent link to this record
http://hdl.handle.net/20.500.12613/5463
Metadata
Show full item recordDOI
10.1371/journal.pcbi.1002507Abstract
The evolution of substitutions conferring drug resistance to HIV-1 is both episodic, occurring when patients are on antiretroviral therapy, and strongly directional, with site-specific resistant residues increasing in frequency over time. While methods exist to detect episodic diversifying selection and continuous directional selection, no evolutionary model combining these two properties has been proposed. We present two models of episodic directional selection (MEDS and EDEPS) which allow the a priori specification of lineages expected to have undergone directional selection. The models infer the sites and target residues that were likely subject to directional selection, using either codon or protein sequences. Compared to its null model of episodic diversifying selection, MEDS provides a superior fit to most sites known to be involved in drug resistance, and neither one test for episodic diversifying selection nor another for constant directional selection are able to detect as many true positives as MEDS and EDEPS while maintaining acceptable levels of false positives. This suggests that episodic directional selection is a better description of the process driving the evolution of drug resistance. © 2012 Murrell et al.Citation to related work
Public Library of Science (PLoS)Has part
PLoS Computational BiologyADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduae974a485f413a2113503eed53cd6c53
http://dx.doi.org/10.34944/dspace/5445